Pharmacokinetic modelling of N-(4-[18F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
Valentina Di Gialleonardo(University Medical Center Groningen), Erik F. J. de Vries(University Medical Center Groningen), Rudi Dierckx(University Medical Center Groningen), Jürgen W. A. Sijbesma(University Medical Center Groningen), Alberto Signore(CTO Andrea Alesini), Antoon T. M. Willemsen(University Medical Center Groningen)
Cited by 40
Related Papers
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy
|Journal of Psychopharmacology|2017|279
The Use of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mrow><mml:mn mathvariant="bold">18</mml:mn></mml:mrow></mml:mrow></mml:math>F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
|Clinical and Developmental Immunology|2013|245